Brenzys (etanercept)

pCPA File Number: 20925
Negotiation Status:
Concluded with an LOI
Indication(s):
Rheumatoid Arthritis and Ankylosing Spondylitis
Sponsor/Manufacturer:
Merck Canada Inc.
CDA-AMC Project Number:
SE0485-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: